<DOC>
	<DOCNO>NCT02262065</DOCNO>
	<brief_summary>Assessment cytokine polymorphism 100 patient aseptic complication arthroplasty compare 100 symptom-free arthroplasty patient . In selected patient additional in-vitro cytokine release assay peripheral blood mononuclear cell ( PBMC ) stimulate different wear particle .</brief_summary>
	<brief_title>Risk Factors Enhanced Inflammation Arthroplasty Wear Particles : Analysis Cytokine Production Polymorphisms</brief_title>
	<detailed_description>A cytokine polymorphism analysis 100 individual aseptic implant intolerance reaction ( patient implant allergy special ambulance ) 100 asymptomatic patient implanted endoprostheses do . Furthermore , supplementary clinical data ( type implant , hospital stay , discomfort ) , questionnaire-based history clinical score ( WOMAC score ) record . In subgroup analysis 10 patient implant patient complaint special find cytokine polymorphism 10 implant patient without problem cytokine response particle vitro assess . Test parameter : 1. total collective : DNA cryopreserved blood sample isolate . By polymerase chain reaction , four different know polymorphism analyze , three IL-1B gene ( IL-1B-3954 IL-1B-31 , IL-1B-511 ) , IL-1ß receptor antagonist gene ( IL -1-RN , intron 2 VNTR ) . Molecular analysis include DNA isolation , polymerase chain reaction ( PCR ) gel electrophoresis . 2 . Subgroup analysis : Peripheral blood cell isolate 10 implant patient complication 10 symptom-free person stimulate cell culture control stimulus , IL-1ß-inducer lipopolysaccharide ( LPS ) ceramic particle ( BIOLOX delta ) * , CoCrMo particles XPE-particles** cultured separately combination . The secretion IL-1ß select proinflammatory cytokine measure . The method include cell isolation density centrifugation analysis cell culture supernatant multiplex cytokine measurement assay flow cytometry . * Supplied CeramTec ** Generated process Working Group cooperation partner Prof. R. Bader ( University Hospital Rostock ) special carrier system cell culture stimulation approach</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<criteria>arthroplasty 18 year infection inability consent malposition infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>implant</keyword>
	<keyword>allergy</keyword>
	<keyword>particle</keyword>
	<keyword>cytokine</keyword>
</DOC>